Search research articles
Contact Us
Filters
Showing results (481-490 of 505) with videos related to
Page
of 51
Sort By:
Journal of Experimental Botany
|
March 31, 2022
European traditional tomatoes galore: a result of farmers' selection of a few diversity-rich loci
Jose Blanca, Clara Pons, Javier Montero-Pau, et al.
BMC Public Health
|
March 3, 2021
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort
Hervé Ghesquières, Cédric Rossi, Fanny Cherblanc, et al.
Open Forum Infectious Diseases
|
January 28, 2025
Correlates of Protection Against Symptomatic COVID-19: The CORSER 5 Case-Control Study
Léopold Beeker, Thomas Obadia, Emma Bloch, et al.
Cell Reports
|
March 28, 2019
PRDM12 Is Required for Initiation of the Nociceptive Neuron Lineage during Neurogenesis
Luca Bartesaghi, Yiqiao Wang, Paula Fontanet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2023
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
Pier Luigi Zinzani, Jiří Mayer, Christopher R Flowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study
Guillaume Cartron, Emmanuel Bachy, Hervé Tilly, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2024
Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort
Amélie Anota, Mathurine Basset, Emilie Charton, et al.
HIV Medicine
|
January 20, 2012
Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs
V Ceperuelo-Mallafré, X Escoté, C Viladés, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2021
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma
Stephen Opat, Alessandra Tedeschi, Kim Linton, et al.
Frontiers in Epidemiology
|
March 8, 2024
Unravelling the determinants of human health in French Polynesia: the MATAEA project
Iotefa Teiti, Maite Aubry, Sandrine Fernandes-Pellerin, et al.
Page
of 51
Search research articles
Search
Showing results (481-490 of 505) with videos related to
Sort By:
Page
of 51
Journal of Experimental Botany
|
March 31, 2022
European traditional tomatoes galore: a result of farmers' selection of a few diversity-rich loci
Jose Blanca, Clara Pons, Javier Montero-Pau, et al.
BMC Public Health
|
March 3, 2021
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort
Hervé Ghesquières, Cédric Rossi, Fanny Cherblanc, et al.
Open Forum Infectious Diseases
|
January 28, 2025
Correlates of Protection Against Symptomatic COVID-19: The CORSER 5 Case-Control Study
Léopold Beeker, Thomas Obadia, Emma Bloch, et al.
Cell Reports
|
March 28, 2019
PRDM12 Is Required for Initiation of the Nociceptive Neuron Lineage during Neurogenesis
Luca Bartesaghi, Yiqiao Wang, Paula Fontanet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2023
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
Pier Luigi Zinzani, Jiří Mayer, Christopher R Flowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study
Guillaume Cartron, Emmanuel Bachy, Hervé Tilly, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2024
Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort
Amélie Anota, Mathurine Basset, Emilie Charton, et al.
HIV Medicine
|
January 20, 2012
Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs
V Ceperuelo-Mallafré, X Escoté, C Viladés, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2021
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma
Stephen Opat, Alessandra Tedeschi, Kim Linton, et al.
Frontiers in Epidemiology
|
March 8, 2024
Unravelling the determinants of human health in French Polynesia: the MATAEA project
Iotefa Teiti, Maite Aubry, Sandrine Fernandes-Pellerin, et al.
Page
of 51